Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
RBD1016 / Suzhou Ribo
NCT05961098: A Study of RBD1016 in CHB Participants	Active, not recruiting	2	48	Europe, RoW	RBD1016	Suzhou Ribo Life Science Co. Ltd.	Chronic Hepatitis B	04/25	12/25
NCT05017116: A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) Infection	Completed	1	40	RoW	RBD1016, RBD1016 injection, Placebo, Entecavir	Suzhou Ribo Life Science Co. Ltd.	Chronic Hepatitis B	10/23	10/23